PRISM Race and Communication Pilot RCT
Completed · Phase 1/Phase 2
Conditions studied: Discrimination, Racial, Communication, Chronic Illness, Bias, Racial
In brief
This is a pilot randomized trial of 60 patients to test feasibility, acceptability and efficacy of PRISM to improve resilience and facilitate improved patient-clinician communication in racially minorities patients with serious illness.
Key facts
- Study ID
- NCT04915079
- Run by
- University of Washington
- People needed
- 28
- Starts
- 2023-07-19
- Expected to finish
- 2025-08-29
- Last updated by the study team
- 2026-04-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Seriously ill adults with median life expectancy of two years or less (e.g. metastatic cancer or inoperable lung cancer, chronic obstructive pulmonary disease (COPD) with forced expiratory volume in 1 second (FEV1) <35% predicted or oxygen dependence, restrictive lung disease with total lung capacity (TLC) <50% predicted, New York Heart Association (NYHA) class III or IV heart failure, or Child's class C cirrhosis or Model for End Stage Liver Disease(MELD) >17)
- Hospitalized at either Harborview Medical Center or University of Washington Medical Center-Montlake
- At least 18 years of age
- English-speaking
- No cognitive impairment precluding completion of surveys or participation in the PRISM sessions
You may not qualify if…
- Younger than 18 years of age
- Non-English speaking
- Ccgnitive impairment that would preclude completion of surveys and participation in the PRISM sessions.
Where it is running
- University of Washington - Harborview Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.